Choi D - Search Results

1

Mirikizumab: A New Therapeutic Option for the Treatment of Ulcerative Colitis.

Choi D, Sheridan H, Bhat S. Choi D, et al. Ann Pharmacother. 2024 Nov;58(11):1134-1139. doi: 10.1177/10600280241229742. Epub 2024 Feb 12. Ann Pharmacother. 2024. PMID: 38344998 Review.

2

Ozanimod: A First-in-Class Sphingosine 1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis.

Choi D, Stewart AP, Bhat S. Choi D, et al. Ann Pharmacother. 2022 May;56(5):592-599. doi: 10.1177/10600280211041907. Epub 2021 Aug 22. Ann Pharmacother. 2022. PMID: 34423657 Review.

3

Adalimumab-Adbm: The First Interchangeable Biosimilar for the Treatment of Inflammatory Diseases.

Bhat S, Patel M, Duly K, Choi D. Bhat S, et al. Among authors: choi d. Ann Pharmacother. 2022 Dec;56(12):1356-1364. doi: 10.1177/10600280221082196. Epub 2022 Apr 7. Ann Pharmacother. 2022. PMID: 35392668 Review.

4

Evaluating the Incidence and Risk Factors for Acute Cellular Rejection in a Steroid Sparing Liver Transplant Center.

Zhang X, Lichvar A, Chan C, Choi D. Zhang X, et al. Among authors: choi d. Ann Pharmacother. 2023 May;57(5):553-559. doi: 10.1177/10600280221120059. Epub 2022 Aug 24. Ann Pharmacother. 2023. PMID: 36004388

5

Risankizumab-rzaa: A New Therapeutic Option for the Treatment of Crohn's Disease.

Choi D, Sheridan H, Bhat S. Choi D, et al. Ann Pharmacother. 2023 May;57(5):579-584. doi: 10.1177/10600280221130450. Epub 2022 Oct 8. Ann Pharmacother. 2023. PMID: 36214282 Review.

6

Etrasimod: A Sphingosine-1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis.

Choi D, Becker M, Ivanov M, Bhat S. Choi D, et al. Ann Pharmacother. 2024 Oct;58(10):1054-1063. doi: 10.1177/10600280231225770. Epub 2024 Jan 23. Ann Pharmacother. 2024. PMID: 38258760 Review.

7

Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data From a Large Tertiary Center.

Cohen NA, Choi D, Choden T, Cleveland NK, Cohen RD, Rubin DT. Cohen NA, et al. Among authors: choi d. Clin Gastroenterol Hepatol. 2023 Aug;21(9):2407-2409.e2. doi: 10.1016/j.cgh.2022.03.035. Epub 2022 Apr 2. Clin Gastroenterol Hepatol. 2023. PMID: 35381385 Free PMC article.

8

Ozanimod Maintenance Therapy After Cyclosporine Induction in Acute Severe Ulcerative Colitis.

Cohen NA, Dalal SR, Choi D, Rubin DT. Cohen NA, et al. Among authors: choi d. ACG Case Rep J. 2022 Jul 21;9(7):e00832. doi: 10.14309/crj.0000000000000832. eCollection 2022 Jul. ACG Case Rep J. 2022. PMID: 35919406 Free PMC article.

9

Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn's Disease: Prospective Real-World Experience.

Friedberg S, Choi D, Hunold T, Choi NK, Garcia NM, Picker EA, Cohen NA, Cohen RD, Dalal SR, Pekow J, Sakuraba A, Krugliak Cleveland N, Rubin DT. Friedberg S, et al. Among authors: choi nk, choi d. Clin Gastroenterol Hepatol. 2023 Jul;21(7):1913-1923.e2. doi: 10.1016/j.cgh.2023.03.001. Epub 2023 Mar 8. Clin Gastroenterol Hepatol. 2023. PMID: 36898598 Free PMC article.

10

Ozanimod-exposed Patients with Ulcerative Colitis Undergoing Total Colectomy Exhibit Unique Lymph Node Histological Changes.

Cohen NA, Weber CR, Cheng JX, Choi D, Garcia NM, Choi NK, Rubin DT. Cohen NA, et al. Among authors: choi nk, choi d. J Crohns Colitis. 2024 Apr 23;18(4):638-641. doi: 10.1093/ecco-jcc/jjad174. J Crohns Colitis. 2024. PMID: 37879626

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,817 results

Search Page

Filters